MMI News

Marcus & Millichap Declares Regular Semi-Annual Dividend of $0.25 Per Share

MMI Receives FDA Approval to Advance to Phase II of Patient Enrollment in Groundbreaking REMIND Microsurgical Study in Alzheimer’s Patients

Marcus & Millichap Selects Deferred as Preferred 1031 Exchange Provider

Marcus & Millichap’s IPA Capital Markets Bolsters Its Eastern Region Capital Markets Team

Marcus & Millichap Brokers $51 Million Sale of 132-Unit Los Angeles Multifamily Asset

Marcus & Millichap Names Brown & Brown Preferred Partner for Insurance and Risk Management

Marcus & Millichap Capital Corporation Arranges $85 Million in Construction Financing for Beverly Hills Mixed-Use Development

$123 Million Financing Arranged by Marcus & Millichap’s IPA Capital Markets for Bay Area Multifamily Property

$910 Million Student Housing Portfolio Sale Facilitated by Institutional Property Advisors

Marcus & Millichap Closes $42 Million Two-Property Industrial Sale in Northern Virginia’s Data Center Corridor